DK175841B1 - Behandling af hypertension - Google Patents

Behandling af hypertension Download PDF

Info

Publication number
DK175841B1
DK175841B1 DK199100726A DK72691A DK175841B1 DK 175841 B1 DK175841 B1 DK 175841B1 DK 199100726 A DK199100726 A DK 199100726A DK 72691 A DK72691 A DK 72691A DK 175841 B1 DK175841 B1 DK 175841B1
Authority
DK
Denmark
Prior art keywords
hypertension
hydrogen carbonate
potassium hydrogen
potassium
blood pressure
Prior art date
Application number
DK199100726A
Other languages
Danish (da)
English (en)
Other versions
DK72691A (da
DK72691D0 (da
Inventor
R Morris Curtis Jr
Anthony Sebastian
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of DK72691D0 publication Critical patent/DK72691D0/da
Publication of DK72691A publication Critical patent/DK72691A/da
Application granted granted Critical
Publication of DK175841B1 publication Critical patent/DK175841B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK199100726A 1988-10-21 1991-04-19 Behandling af hypertension DK175841B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26085688A 1988-10-21 1988-10-21
US26085688 1988-10-21
US8904771 1989-10-20
PCT/US1989/004771 WO1990004403A1 (fr) 1988-10-21 1989-10-20 Traitement de l'hypertension

Publications (3)

Publication Number Publication Date
DK72691D0 DK72691D0 (da) 1991-04-19
DK72691A DK72691A (da) 1991-04-22
DK175841B1 true DK175841B1 (da) 2005-03-29

Family

ID=22990921

Family Applications (2)

Application Number Title Priority Date Filing Date
DK199100726A DK175841B1 (da) 1988-10-21 1991-04-19 Behandling af hypertension
DK199100727A DK175840B1 (da) 1988-10-21 1991-04-19 Behandling af osteoporose

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK199100727A DK175840B1 (da) 1988-10-21 1991-04-19 Behandling af osteoporose

Country Status (13)

Country Link
US (1) US5804204A (fr)
EP (3) EP0440738B1 (fr)
JP (2) JP2843146B2 (fr)
KR (2) KR0163583B1 (fr)
AT (1) ATE145825T1 (fr)
AU (2) AU634988B2 (fr)
CA (2) CA2001124C (fr)
DE (2) DE68913311T2 (fr)
DK (2) DK175841B1 (fr)
HU (2) HU212106B (fr)
IL (2) IL92076A (fr)
WO (2) WO1990004402A1 (fr)
ZA (2) ZA898018B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
AT408416B (de) * 1996-07-19 2001-11-26 Norbert Fuchs Pharmazeutische bzw. diätetische zusammensetzungen
EP1350515A1 (fr) * 2002-04-05 2003-10-08 Btg International Limited Supplément de potassium à faible dose pour la prévention et la thérapie de l'hypertension
AU2003219321A1 (en) * 2002-04-05 2003-10-27 Btg International Limited Low-dose potassium supplementation for the prevention and treatment of hypertension
US20040202726A1 (en) * 2003-04-10 2004-10-14 Deshay Samuel L. Topical blood pressure composition
US10251909B2 (en) * 2007-02-09 2019-04-09 Board Of Regents, The University Of Texas System Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension
US20090022853A1 (en) * 2007-07-16 2009-01-22 Conopco, Inc., D/B/A Unilever Beverage
US20090196957A1 (en) * 2008-02-06 2009-08-06 Campbell Soup Company Methods and compositions for reducing sodium content in food products
US20110195172A1 (en) * 2008-09-05 2011-08-11 Inge Elisabeth Maria Deutz Beverages comprising potassium
CN114272263A (zh) * 2022-01-10 2022-04-05 伍永田 一种用于治疗高血压疾病的水配方

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2611730A (en) * 1950-09-02 1952-09-23 Simth Kline & French Lab Medical preparation for reducing the body level of sodium
GB1195381A (en) * 1967-04-28 1970-06-17 Arthur H Cox & Company Ltd Pharmaceutical Compositions Comprising Potassium and Chlorine
US3639585A (en) * 1968-03-29 1972-02-01 Res Inst Medicine Chem Method of preventing corticosteroid-induced adverse effects on bon and compositions useful in said method
US3541208A (en) * 1968-09-10 1970-11-17 Arcom Holding Corp Relief of arthritis with a soluble silicate and a soluble polyphosphate
US3921804A (en) * 1974-05-09 1975-11-25 William W Tester Medication dispensing package
SU858830A1 (ru) * 1974-10-23 1981-08-30 Институт медико-биологических проблем Средство дл лечени нарушений ритма сердца
SU946545A1 (ru) * 1978-05-04 1982-07-30 Институт Медико-Биологических Проблем Министерства Здравоохранения Ссср Способ восполнени калиевого дефицита в ткан х
FR2432869A1 (fr) * 1978-08-08 1980-03-07 Armour Montagu Laboratoire Compositions pour le traitement de l'osteoporose associant la calcitonine et le phosphore
US4289750A (en) * 1978-10-16 1981-09-15 Kopp Klaus F Therapy of conditions which may be associated with altered renal function and dosage forms therefor
US4405596A (en) * 1978-10-16 1983-09-20 Helbig Joachim W Pharmaceutical preparations for and treatment procedures involving increasing plasma bicarbonate level
US4451454A (en) * 1981-06-16 1984-05-29 Wong Dennis W Prophylaxis and treatment of thromboembolic disorders in man and in warm-blooded animals with bicarbonate salts of alkali metals
US4704269A (en) * 1985-06-11 1987-11-03 Hudson Pharmaceutical Corporation Effervescent antacid and analgesic compositions
JPH0619063B2 (ja) * 1986-04-09 1994-03-16 日本エステル株式会社 粉体塗料用樹脂組成物

Also Published As

Publication number Publication date
JP2843146B2 (ja) 1999-01-06
DE68913311D1 (de) 1994-03-31
HU896567D0 (en) 1991-07-29
HU896889D0 (en) 1991-07-29
DK72691A (da) 1991-04-22
EP0440738B1 (fr) 1996-12-04
HU212106B (en) 1996-02-28
IL92076A (en) 1995-08-31
WO1990004402A1 (fr) 1990-05-03
JPH04501419A (ja) 1992-03-12
CA2001124C (fr) 2000-01-18
IL92076A0 (en) 1990-07-12
HU208923B (en) 1994-02-28
KR0163583B1 (ko) 1998-12-01
AU634988B2 (en) 1993-03-11
DE68927519D1 (de) 1997-01-16
IL92075A0 (en) 1990-07-12
ATE145825T1 (de) 1996-12-15
CA2001123C (fr) 2000-01-18
CA2001124A1 (fr) 1990-04-21
WO1990004403A1 (fr) 1990-05-03
DE68927519T2 (de) 1997-04-03
DK72791D0 (da) 1991-04-19
DK175840B1 (da) 2005-03-29
AU4622089A (en) 1990-05-14
DK72691D0 (da) 1991-04-19
HUT57989A (en) 1992-01-28
EP0440738A1 (fr) 1991-08-14
ZA898017B (en) 1990-12-28
CA2001123A1 (fr) 1990-04-21
IL92075A (en) 1995-07-31
HUT63058A (en) 1993-07-28
KR0178033B1 (ko) 1999-03-20
AU635231B2 (en) 1993-03-18
JP2948247B2 (ja) 1999-09-13
DE68913311T2 (de) 1994-05-26
EP0461111B1 (fr) 1994-02-23
AU4515489A (en) 1990-05-14
EP0720855A2 (fr) 1996-07-10
JPH04501724A (ja) 1992-03-26
KR900701287A (ko) 1990-12-01
EP0720855A3 (fr) 1998-07-08
DK72791A (da) 1991-05-14
ZA898018B (en) 1990-12-28
KR900701288A (ko) 1990-12-01
US5804204A (en) 1998-09-08
EP0461111A4 (fr) 1991-07-25
EP0440738A4 (en) 1991-08-28
EP0461111A1 (fr) 1991-12-18

Similar Documents

Publication Publication Date Title
Dahlöf et al. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension)
CA1308659C (fr) Methode de reduction de la mortalite associee a l'insuffisance cardiaque congestive faisant appel a l'hydralazine et au dinitrate d'isosobide
Pedersen et al. Acute and chronic effects of nifedipine in arterial hypertension
PUDENZ et al. The role of potassium in familial periodic paralysis
DK175841B1 (da) Behandling af hypertension
Frenneaux et al. Enalapril for severe heart failure in infancy.
US5171583A (en) Treatment of osteoporosis using potassium bicarbonate
Jäättelä Clinical efficacy of BS 100-141 in essential hypertension: A single-blind pilot study
US11596166B2 (en) Compositions and methods for treating aging and/or improving human health
Tjoa et al. Treatment of hypertension in the elderly
US5498428A (en) Treatment of hypertension by oral administration of potassium bicarbonate
Langman et al. Treatment of chronic gastric ulcer with carbenoxolone and gefarnate: A comparative trial
US5766640A (en) Simutaneous treatment of osteoporosis and hypertension
Spingarn et al. Orthostatic circulatory insufficiency: its occurrence in tabes dorsalis and Addison's disease
Lepäntalo et al. Effect of long‐term beta‐adrenergic‐blockade on calf blood flow in hypertensive patients
Seedat, YK, Hoosen, S. & Bhigjee Reserpine plus hydrochlorothiazide and sotalol plus hydrochlorothiazide in black and Indian hypertensive patients
Seedat, YK, North-Coombes, D. & Rampono Prazosin in the treatment of hypertenstion-a preliminary study
Johnson et al. A multicenter comparison of adverse reaction profiles of isradipine and enalapril at equipotent doses in patients with essential hypertension
Smith et al. Propranolol in the management of hypertension in a long-term dialysis program
Upward et al. Oral labetalol in the management of stable angina pectoris in normotensive patients.
Moser The management of cardiovascular disease in the elderly
BLUMGART The management of congestive heart failure
Burns, DG & Pittaway Combination of timolol maleate, hydrochlorothiazide and amiloride hydrochloride in the treatment of hypertension-a multicentre trial
Cleghorn Recognition and treatment of Addison's disease
Mccardell et al. Acute pulmonary edema associated with placement of waist-high, custom-fit compression stockings

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK